EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Crosstalk Between CTSB + Glioblastoma Cells and S100A10 + Macrophages: A Self‐Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy

Hao Zhang iD, Nan Zhang iD, Xisong Liang iD, Jie Wen iD, Ziyu Dai iD, Wantao Wu iD, Shuyu Li iD, Songshan Feng iD, Zaoqu Liu iD, Zhiwei Xia iD, Peng Luo iD, Quan Cheng iD

Advanced Science · 2026

DOI: 10.1002/advs.76905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Hao Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Macrophages, Brain Neoplasms. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Medical Youth Top Talent Program, Chongqing Youth Innovation Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) establishes a highly immunosuppressive microenvironment through intricate molecular dialogues with tumor‐associated macrophages (TAMs), contributing to immunotherapy resistance.

Methods

We integrated advanced biological network analyses with multimodal AI to identify CTSB as a key biomarker. Functional validation included GBM‐macrophage co‐culture systems, chromatin immunoprecipitation (ChIP), dual‐luciferase reporter assays, molecular docking, and co‐immunoprecipitation (Co‐IP). In vivo experiments employed orthotopic (GL261 and CT‐2A) and subcutaneous GBM models with lentivirus‐mediated CTSB knockdown and anti‐PD‐1 therapy. Tumor microenvironment dynamics were assessed via in‐house generated single‐cell RNA sequencing and multiplex immunofluorescence.

Results

Cathepsin B (CTSB) was identified as a critical driver of aggressive GBM progression and poor outcomes. Mechanistically, macrophage‐derived IL‐6 activates STAT3 in tumor cells, upregulating CTSB expression. Structural and Co‐IP analyses revealed CTSB, secreted by tumor cells, binds the C‐terminus of macrophage S100A10, reinforcing IL‐6 secretion, forming a feedforward loop between CTSB + GBM cells and S100A10 + macrophages. This loop enhances tumor growth, invasion, and immune evasion via PD‐L1 upregulation. In vivo, CTSB blockade reduced TAM activation, increased CD8 + T cell infiltration, and synergized with anti‐PD‐1 therapy.

Conclusions

This study unveils a targetable GBM‐macrophage signaling axis, proposing CTSB inhibition as a strategy to enhance immunotherapy efficacy in GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaImmunotherapyMacrophagesBrain NeoplasmsAnnexin A2Tumor-Associated MacrophagesS100 ProteinsAnimalsHumansMiceTumor MicroenvironmentS100 Calcium Binding Protein A10Cell Line, TumorImmune Evasion

Stichwörter der Autor:innen

CTSBS100A10glioblastomaimmunotherapytumor‐associated macrophage

Substanzen

S100 Calcium Binding Protein A10Annexin A2S100 Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
  • National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Central South University, Changsha, China.
  • Western Institute of Digital-Intelligent Medicine, Chongqing, China.
  • Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumor Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wu…

ORCID-Profile: Hao Zhang, Nan Zhang, Xisong Liang, Jie Wen, Ziyu Dai, Wantao Wu, Shuyu Li, Songshan Feng, Zaoqu Liu, Zhiwei Xia, Peng Luo, Quan Cheng

Förderung

  • National Natural Science Foundation of China
  • Chongqing Medical Youth Top Talent Program
  • Chongqing Youth Innovation Talent Project
  • Science and Technology Innovation Program of Hunan Province
  • Key R&D Program of Jiangxi Province
  • Jiangxi Provincial Health Technology Project
  • Beijing Xisike Clinical Oncology Research Foundation
  • Jiangxi Provincial Natural Science Foundation

Zitieren

APA

Zhang, H., Zhang, N., Liang, X., Wen, J., Dai, Z., Wu, W., Li, S., Feng, S., Liu, Z., Xia, Z., Luo, P., & Cheng, Q. (2026). Crosstalk Between CTSB + Glioblastoma Cells and S100A10 + Macrophages: A Self‐Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.76905

Vancouver

Zhang H, Zhang N, Liang X, Wen J, Dai Z, Wu W, et al. Crosstalk Between CTSB + Glioblastoma Cells and S100A10 + Macrophages: A Self‐Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy. Advanced Science. 2026. doi:10.1002/advs.76905

BibTeX
@article{Zhang2026,
  author = {Zhang, Hao and Zhang, Nan and Liang, Xisong and Wen, Jie and Dai, Ziyu and Wu, Wantao and Li, Shuyu and Feng, Songshan and Liu, Zaoqu and Xia, Zhiwei and Luo, Peng and Cheng, Quan},
  title = {Crosstalk Between CTSB + Glioblastoma Cells and S100A10 + Macrophages: A Self‐Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76905}
}
Kostenlos starten →